Showing results (81-90 of 174) with videos related to

Sort By:
Pageof 18
Frontiers in Immunology|December 12, 2018
Identification of CVID Patients With Defects in Immune Repertoire Formation or SpecificationPauline A van Schouwenburg, Hanna IJspeert, Ingrid Pico-Knijnenburg, et al.
International Journal of Molecular Sciences|February 27, 2026
Generation of Functionally Competent Human Mast Cells from Limited Blood VolumesSanne J van de Meerendonk, Michelle du Toit, Vincent H J van der Velden, et al.
Asian Pacific Journal of Allergy and Immunology|August 24, 2020
A pilot study into bosentan (Tracleer®) as an immunomodulating agent in patients with Behçet's diseaseTim B van der Houwen, P Martin van Hagen, Jasper H Kappen, et al.
Frontiers in Immunology|March 29, 2017
A Novel Heterozygous Mutation in the <i>STAT1</i> SH2 Domain Causes Chronic Mucocutaneous Candidiasis, Atypically Diverse Infections, Autoimmunity, and Impaired Cytokine RegulationKornvalee Meesilpavikkai, Willem A Dik, Benjamin Schrijver, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 9, 2014
Intravenous immunoglobulin treatment in humans suppresses dendritic cell function via stimulation of IL-4 and IL-13 productionAngela S W Tjon, Rogier van Gent, Haziz Jaadar, et al.
Rheumatology (Oxford, England)|October 31, 2014
Prevalence of distal renal tubular acidosis in primary Sjögren's syndromeTim Both, Ewout J Hoorn, Robert Zietse, et al.
Acta Ophthalmologica|January 10, 2021
A pilot study on the use of prednisolone-encapsulated liposomes for the treatment of moderate-to-severe Graves' orbitopathy with reduced systemic steroid exposureSanne E Detiger, Tessa M Kremer, Virgil A S H Dalm, et al.
Investigative Ophthalmology & Visual Science|February 24, 2009
Imatinib mesylate and AMN107 inhibit PDGF-signaling in orbital fibroblasts: a potential treatment for Graves' ophthalmopathyLeendert van Steensel, Dion Paridaens, Benjamin Schrijver, et al.
Frontiers in Ophthalmology|June 19, 2025
Exploiting induced pluripotent stem cell-derived retinal pigment epithelium to unravel host-pathogen interaction in ocular tuberculosis: a reverse translational <i>in vitro</i> modelIkhwanuliman Putera, Sanne van de Meerendonk, Nicole M A Nagtzaam, et al.
Clinical and Experimental Rheumatology|March 16, 2019
Adalimumab provides long-lasting clinical improvement in refractory mucocutaneous Behçet's disease without formation of antidrug antibodiesDiana M Verboom, Tim B van der Houwen, Jasper H Kappen, et al.
Pageof 18